Advisor Live: Hepatitis C Screening and Linkage to Care

July 7, 2016
Hepatitis C (HCV) is the leading cause of liver transplants in the U.S., with an estimated cost of $600,000 per case. The Centers for Disease Control and Prevention (CDC) recommends HCV testing for everyone born between 1945 and 1965. A new core measure set for the Core Quality Measures Collaborative now includes an HCV testing measure for all at-risk patients. This webinar reviews: The prevalence of HCV Populations at risk Screening and treatment EXPERT YOU WILL HEAR FROM Radha Hussain, PharmD, AAHIVP, Clinical Pharmacist
Previous Presentation
Advisor Live: Antimicrobial Stewardship - Why Now and How?
Advisor Live: Antimicrobial Stewardship - Why Now and How?

This 90-minute webinar discusses strategies and tools for implementing antimicrobial stewardship programs, ...

No More Presentations